Mycobacterium chelonae sensitisation induces CD4+-mediated cytotoxicity against BCG

European Journal of Immunology

Volumn 39, Issue 7, 2009, Pages 1841-1849

  Ho, Peiying ^a   Zhang, Lin ^a,b   Wei, Xing ^a   Seah, Geok Teng ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Bacterial infections; CD4 T cells; Cytotoxicity; Host pathogen interactions; Immune responses

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; FAS LIGAND; GAMMA INTERFERON; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; CYTOTOXICITY; IMMUNE RESPONSE; MOUSE; MYCOBACTERIUM CHELONEI; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES; ANTIGENS, CD56; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; FLOW CYTOMETRY; INTERFERON-GAMMA; INTERLEUKIN-10; LUNG; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; MYCOBACTERIUM CHELONAE; PERFORIN; TUBERCULOSIS;

EID: 69249141058     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838933     Document Type: Article

References (53)

1. Fine, P. E. and Vynnycky, E., The effect of heterologous immunity upon the apparent efficacy of (e.g. BCG) vaccines. Vaccine 1998. 16: 1923-1928.
2. Chilima, B. Z., Clark, I. M., Floyd, S., Fine, P. E. and Hirsch, P. R., Distribution of environmental mycobacteria in Karonga District, northern Malawi. Appl. Environ. Microbiol. 2006. 72: 2343-2350.
3. Black, G. F., Dockrell, H. M., Crampin, A. C., Floyd, S., Weir, R. E., Bliss, L., Sichali, L. et al., Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J. Infect. Dis. 2001. 184: 322-329.
4. Fine, P. E., BCG: The challenge continues. Scand. J. Infect. Dis. 2001. 33: 243-245.
5. Smith, D., Wiegeshaus, E. and Balasubramanian, V., An analysis of some hypotheses related to the Chingelput bacille Calmette-Guerin trial. Clin. Infect. Dis. 2000. 31: S77-S80.
6. Brandt, L., Feino Cunha, J., Weinreich Olsen, A., Chilima, B., Hirsch, P., Appelberg, R. and Andersen, P., Failure of the Mycobacterium bovis BCG vaccine: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 2002. 70: 672-678.
7. Buddle, B. M., Wards, B. J., Aldwell, F. E., Collins, D. M. and de Lisle, G.W., Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 2002. 20: 1126-1133.
8. de Lisle, G. W., Wards, B. J., Buddle, B. M. and Collins, D. M., The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium. Tuberculosis (Edinb) 2005. 85: 73-79.
9. Stahl, D. A. and Urbance, J. W., The division between fast- and slow-growing species corresponds to natural relationships among the mycobacteria. J. Bacteriol. 1990. 172: 116-124.
10. Tortoli, E., Impact of genotypic studies on mycobacterial taxonomy: The new mycobacteria of the 1990s. Clin. Microbiol. Rev. 2003. 16: 319-354.
11. Palmer, C. E. and Long, M. W., Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am. Rev. Respir. Dis. 1966. 94: 553-568.
12. Ponnighaus, J. M., Fine, P. E., Sterne, J. A., Wilson, R. J., Msosa, E., Gruer, P. J., Jenkins, P. A. et al., Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet 1992. 339: 636-639.
13. Demangel, C., Garnier, T., Rosenkrands, I. and Cole, S. T., Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens. Infect. Immun. 2005. 73: 2190-2196.
14. Tan, J. S., Canaday, D. H., Boom,W. H., Balaji, K. N., Schwander, S. K. and Rich, E. A., Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: Role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J. Immunol. 1997. 159: 290-297.
15. Stenger, S., Mazzaccaro, R. J., Uyemura, K., Cho, S., Barnes, P. F., Rosat, J. P., Sette, A. et al., Differential effects of cytolytic T cell subsets on intracellular infection. Science 1997. 276: 1684-1687.
16. Stenger, S., Hanson, D. A., Teitelbaum, R., Dewan, P., Niazi, K. R., Froelich, C. J., Ganz, T. et al., An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998. 282: 121-125.
17. Boselli, D., Losana, G., Bernabei, P., Bosisio, D., Drysdale, P., Kiessling, R., Gaston, J. S. et al., IFN-gamma regulates Fas ligand expression in human CD41 T lymphocytes and controls their anti-mycobacterial cytotoxic functions. Eur. J. Immunol. 2007. 37: 2196-2204.
18. Black, G. F., Fine, P. E. M., Warndorff, D. K., Floyd, S., Weir, R. E., Blackwell, J. M., Bliss, L. et al., Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Int. J. Tuberc. Lung Dis. 2001. 5: 664-672.
19. Young, S. L., Slobbe, L., Wilson, R., Buddle, B. M., de Lisle, G. W. and Buchan, G. S., Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination. Infect. Immun. 2007. 75: 2833-2840.
20. Boom, W. H., Wallis, R. S. and Chervenak, K. A., Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes. Infect. Immun. 1991. 59: 2737-2743.
21. Hancock, G. E., Cohn, Z. A. and Kaplan, G., The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2. J. Exp. Med. 1989. 169: 909-919.
22. Lorgat, F., Keraan, M. M., Lukey, P. T. and Ress, S. R., Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am. Rev. Respir. Dis. 1992. 145: 418-423.
23. Pithie, A. D., Rahelu, M., Kumararatne, D. S., Drysdale, P., Gaston, J. S., Iles, P. B., Innes, J. A. et al., Generation of cytolytic T cells in individuals infected by Mycobacterium tuberculosis and vaccinated with BCG. Thorax 1992. 47: 695-701.
24. Silva, C. L. and Lowrie, D. B., Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis. Infect. Immun. 2000. 68: 3269-3274.
25. Mustafa, A. S. and Godal, T., BCG induced CD4+ cytotoxic T cells from BCG vaccinated healthy subjects: Relation between cytotoxicity and suppression in vitro. Clin. Exp. Immunol. 1987. 69: 255-262.
26. De La Barrera, S. S., Finiasz, M., Frias, A., Aleman, M., Barrionuevo, P., Fink, S., Franco, M. C. et al., Specific lytic activity against mycobacterial antigens is inversely correlatedwith the severity of tuberculosis. Clin. Exp. Immunol. 2003. 132: 450-461.
27. Sousa, A. O., Mazzaccaro, R. J., Russell, R. G., Lee, F. K., Turner, O. C., Hong, S., Van Kaer, L. et al., Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA 2000. 97: 4204-4208.
28. Sada-Ovalle, I., Torre-Bouscoulet, L., Valdez-Vazquez, R.,Martinez-Cairo, S., Zenteno, E. and Lascurain, R., Characterization of a cytotoxic CD57+ T cell subset from patients with pulmonary tuberculosis. Clin. Immunol. 2006. 121: 314-323.
29. Billeskov, R., Vingsbo-Lundberg, C., Andersen, P. and Dietrich, J., Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1. J. Immunol. 2007. 179: 3973-3981.
30. Stegelmann, F., Bastian, M., Swoboda, K., Bhat, R., Kiessler, V., Krensky, A. M., Roellinghoff, M. et al., Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against Mycobacterium tuberculosis. J. Immunol. 2005. 175: 7474-7483.
31. Smith, S. M., Klein, M. R., Malin, A. S., Sillah, J., Huygen, K., Andersen, P., McAdam, K. P. et al., Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia. Infect. Immun. 2000. 68: 7144-7148.
32. Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B. and Bloom, B. R., Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 1992. 89: 12013-12017.
33. Mogues, T., Goodrich, M. E., Ryan, L., LaCourse, R. and North, R. J., The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 2001. 193: 271-280.
34. Xing, Z., Wang, J., Croitoru, K. and Wakeham, J., Protection by CD4 or CD8 T cells against pulmonary Mycobacterium bovis bacillus Calmette-Guerin infection. Infect. Immun. 1998. 66: 5537-5542.
35. Bermudez, L. E. and Petrofsky, M., Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells. Infect. Immun. 1999. 67: 3108-3111.
36. Orme, I. M., Miller, E. S., Roberts, A. D., Furney, S. K., Griffin, J. P., Dobos, K. M., Chi, D. et al., T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J. Immunol. 1992. 148: 189-196.
37. Saunders, B. M. and Cheers, C., Inflammatory response following intranasal infection with Mycobacterium avium complex: Role of T-cell subsets and gamma interferon. Infect. Immun. 1995. 63: 2282-2287.
38. Lazarevic, V., Nolt, D. and Flynn, J. L., Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses. J. Immunol. 2005. 175: 1107-1117.
39. Lewinsohn, D. M., Alderson, M. R., Briden, A. L., Riddell, S. R., Reed, S. G. and Grabstein, K. H., Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J. Exp. Med. 1998. 187: 1633-1640.
40. Oddo, M., Renno, T., Attinger, A., Bakker, T., MacDonald, H. R. and Meylan, P. R., Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol. 1998. 160: 5448-5454.
41. Canaday, D. H., Wilkinson, R. J., Li, Q., Harding, C. V., Silver, R. F. and Boom, W. H., CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J. Immunol. 2001. 167: 2734-2742.
42. Cooper, A. M., D'Souza, C., Frank, A. A. and Orme, I. M., The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect. Immun. 1997. 65: 1317-1320.
43. Laochumroonvorapong, P., Wang, J., Liu, C. C., Ye, W., Moreira, A. L., Elkon, K. B., Freedman, V. H. et al., Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect. Immun. 1997. 65: 127-132.
44. Yanai, F., Ishii, E., Kojima, K., Hasegawa, A., Azuma, T., Hirose, S., Suga, N. et al., Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells. J. Immunol. 2003. 170: 2205-2213.
45. Cho, S., Mehra, V., Thoma-Uszynski, S., Stenger, S., Serbina, N., Mazzaccaro, R. J., Flynn, J. L. et al., Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc. Natl. Acad. Sci. USA 2000. 97: 12210-12215.
46. Thoma-Uszynski, S., Stenger, S. and Modlin, R. L., CTL-mediated killing of intracellular Mycobacterium tuberculosis is independent of target cell nuclear apoptosis. J. Immunol. 2000. 165: 5773-5779.
47. Fazal, N., Lammas, D. A., Rahelu, M., Pithie, A. D., Gaston, J. S. and Kumararatne, D. S., Lysis of human macrophages by cytolytic CD4+ T cells fails to affect survival of intracellular Mycobacterium bovis-bacille Calmette-Guerin (BCG). Clin. Exp. Immunol. 1995. 99: 82-89.
48. Turner, J., D'Souza, C. D., Pearl, J. E., Marietta, P., Noel, M., Frank, A. A., Appelberg, R. et al., CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. Am. J. Respir. Cell Mol. Biol. 2001. 24: 203-209.
49. Dieli, F., Troye-Blomberg, M., Ivanyi, J., Fournie, J. J., Bonneville, M., Peyrat, M. A., Sireci, G. et al., Vgamma9/ Vdelta2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur. J. Immunol. 2000. 30: 1512-1519.
50. de la Barrera, S., Aleman, M., Musella, R., Schierloh, P., Pasquinelli, V., Garcia, V., Abbate, E. et al., IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients. Clin. Exp. Immunol. 2004. 138: 128-138.
51. Brown, C. A., Brown, I. N. and Swinburne, S., The effect of oral Mycobacterium vaccae on subsequent responses of mice to BCG sensitization. Tubercle 1985. 66: 251-260.
52. Flaherty, D. K., Vesosky, B., Beamer, G. L., Stromberg, P. and Turner, J., Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination. J. Leukoc. Biol. 2006. 80: 1262-1271.
53. Andersen, P. and Doherty, T. M., The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 2005. 3: 656-662.